| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 1.97 bn | 1.97 bn | 1.97 bn | 1.97 bn | 1.97 bn | 1.97 bn |
| Cash burn (monthly) | 1.24 bn | (no burn) | 113.90 mm | (no burn) | 88.94 mm | 64.88 mm |
| Cash used (since last report) | 4.97 bn | n/a | 456.27 mm | n/a | 356.25 mm | 259.89 mm |
| Cash remaining | -3.00 bn | n/a | 1.51 bn | n/a | 1.61 bn | 1.71 bn |
| Runway (months of cash) | -2.4 | n/a | 13.3 | n/a | 18.1 | 26.4 |
| 13F holders | Current |
|---|---|
| Total holders | 295 |
| Opened positions | 55 |
| Closed positions | 53 |
| Increased positions | 121 |
| Reduced positions | 67 |
| 13F shares | Current |
|---|---|
| Total value | 6.41 tn |
| Total shares | 661.29 mm |
| Total puts | 2.52 mm |
| Total calls | 1.26 mm |
| Total put/call ratio | 2.0 |
| Largest owners | Shares | Value |
|---|---|---|
| Dexcel Pharma Technologies | 98.17 mm | $0.00 |
| SB Investment Advisers | 65.93 mm | $760.88 bn |
| QVT Financial | 65.79 mm | $759.26 bn |
| Viking Global Investors | 54.10 mm | $624.30 bn |
| FMR | 49.15 mm | $567.13 bn |
| BlackRock | 41.96 mm | $484.24 bn |
| Vanguard | 41.68 mm | $481.02 bn |
| MS Morgan Stanley | 29.67 mm | $342.44 bn |
| Rubric Capital Management | 22.40 mm | $258.50 bn |
| STT State Street | 19.56 mm | $225.74 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 23 Jan 25 | Vivek Ramaswamy | Common Shares | Gift | Acquire G | Yes | No | 0 | 13,357,857 | 0.00 | 13,357,857 |
| 23 Jan 25 | Vivek Ramaswamy | Common Shares | Gift | Dispose G | No | No | 0 | 13,357,857 | 0.00 | 40,073,570 |
| 23 Jan 25 | Melissa B, Epperly | Common Shares | Payment of exercise | Dispose F | No | No | 11.21 | 180 | 2.02 k | 39,529 |
| 23 Jan 25 | Melissa B, Epperly | Common Shares | Grant | Acquire A | No | No | 0 | 1,672 | 0.00 | 39,709 |
| 23 Jan 25 | Momtazee James C | Common Shares | Payment of exercise | Dispose F | No | No | 11.21 | 306 | 3.43 k | 94,607 |
| 23 Jan 25 | Momtazee James C | Common Shares | Grant | Acquire A | No | No | 0 | 1,248 | 0.00 | 94,913 |
| 23 Jan 25 | Ilan Oren | Common Shares | Payment of exercise | Dispose F | No | No | 11.21 | 313 | 3.51 k | 99,929 |
| 23 Jan 25 | Ilan Oren | Common Shares | Grant | Acquire A | No | No | 0 | 2,386 | 0.00 | 100,242 |
| 20 Jan 25 | Rakhi Kumar | Common Shares | Payment of exercise | Dispose F | No | No | 11.15 | 1,057 | 11.79 k | 203,264 |
